Mineralys Therapeutics
MLYS
#6386
Rank
$0.61 B
Marketcap
$12.34
Share price
4.31%
Change (1 day)
52.53%
Change (1 year)

Mineralys Therapeutics (MLYS) Fails to deliver data

Key failure to deliver metrics for Mineralys Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Mineralys Therapeutics (MLYS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Mineralys Therapeutics (MLYS) - since 2023

Volume in USD (price x number of shares), data since 2023

Mineralys Therapeutics (MLYS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$0.83 M-93.86%
2023$13.68 M